Инциденталома надпочечников

Инциденталома — опухоль надпочечника (-ков), выявленная при радиологическом обследовании не по поводу надпочечниковой патологии. Определяемая таким образом опухоль надпочечника не ограничена никакими функциональными рамками, строгими критериями тканевой принадлежности и т.д. Выявленное образование может оказаться как гормонально-неактивным, так и активно производящим различные гормоны, может исходить из различных зон надпочечника или иметь неспецифичную органную принадлежность, может быть как злокачественной, так и доброкачественной.

1. Allolio B, Fassnacht M. Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-37.

2. Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002;146:61-6.

3. Bovio S, Cataldi A, Reimondo G, et al.Prevalence of adrenal incidentaloma in acontemporary computerized tomographyseries. J Endocrinol Invest 2006;29:298-302.

4. Chiodini I, Tauchmanova L, Torlontano M, et al. Bone involvement in eugonadalmale patients with adrenal incidentaloma and subclinical hypercortisolism. J Clin Endocrinol Metab 2002;87:5491-4.

5. Erbil Y, Ademoglu E, Ozbey N, et al.Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg 2006;30:1665-71.

6. Funder J.W. et al. Guidelines for Management of Patients with Primary Aldosteronism.J Clin Endocrin Metab. First published ahead of print June 13, 2008.

7. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-84.

8. Libe R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B. Longterm follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002;147:489-94.

9. Pacak K. et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. J. Endocrinol & Metab. 2007. Vol. 3, N 2.

10. Rossi R, Tauchmanova L, Luciano A,et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440-8.

11. Szolar DH, Korobkin M, Reittner P, et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrastenhanced CT. Radiology 2005;234:47985.

12. Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002;87:4872-8.

13. Terzolo M, Pia A, Ali A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002;87:998-1003.

14. Young W.F. Jr. Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol MetabClin North Am 2000;29:159-85.

15. Young W.F.,Jr. The Incidentally Discovered Adrenal Mass. N Engl J Med 2007; 356:601-10.